Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ARQL > SEC Filings for ARQL > Form 8-K on 3-Jun-2013All Recent SEC Filings

Show all filings for ARQULE INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ARQULE INC


3-Jun-2013

Regulation FD Disclosure, Financial Statements and Exhibits


Item 7.01 Regulation FD Disclosure.

On June 1, 2013, ArQule, Inc. (the "Registrant") announced final results from a randomized, placebo-controlled, double-blind, phase 2 clinical trial with the selective MET inhibitor tivantinib in combination with cetuximab and irinotecan as an investigational, second-line treatment in KRAS wild-type metastatic colorectal cancer (CRC).

The results were the subject of an oral presentation at the Annual Meeting of the American Society of Clinical Oncology on June 1, 2013. Copies of slides that accompanied the presentation may be accessed electronically at http://investors.arqule.com/data.cfm.

The Registrant's press release dated June 1, 2013, a copy of which is attached hereto as Exhibit 99.1, is incorporated herein by reference.

The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, in accordance with General Instruction B.2 to Form 8-K.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. 99.1 Text of press release announcing clinical trial results dated June 1, 2013.


  Add ARQL to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ARQL - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.